Skip to main content
. 2014 Apr 16;6(4):1103–1113. doi: 10.4161/mabs.28719

Table 5. Statistical summary of PCSK9 data in atorvastatin treated vs. normal subject.

Analysis Parameters Group 1
Normal Subjects
(n = 80)
Group 2
40mg/Day Atorvastatin
(n = 25)
Group 3
80mg/Day Atorvastatin
(n = 30)
Mean (ng/mL) 404 641 751
STD 164.1 141.3 244.4
%CV 41 22 33
Median (ng/mL) 390 668 705
Min (ng/mL) 120 347 424
Max (ng/mL) 800 933 1445

%CV: coefficient of variation calculated as (STD/mean concentration) × 100; STD